Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A B Roberts

Showing results (271-280 of 325) with videos related to

Pageof 33
Sort By:
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Characterization of distinct functional domains of transforming growth factor betaJ K Burmester, S W Qian, A B Roberts, et al.
Surgery Annual|January 1, 1991
Operative ultrasound: ten years of experienceJ Machi, B Sigel, H A Zaren, et al.
The Journal of Biological Chemistry|January 15, 2000
The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domainM P de Caestecker, T Yahata, D Wang, et al.
The Journal of Clinical Investigation|November 1, 1996
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expressionJ J Letterio, A G Geiser, A B Kulkarni, et al.
The Journal of Biological Chemistry|November 29, 1996
Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the moleculeS W Qian, J K Burmester, M L Tsang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsivenessA H Rook, J H Kehrl, L M Wakefield, et al.
Cancer Research|September 1, 1994
Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifenM A Anzano, S W Byers, J M Smith, et al.
The Journal of Biological Chemistry|December 8, 1995
Characterization of the promoter region of the human transforming growth factor-beta type II receptor geneH W Bae, A G Geiser, D H Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic miceK Sellheyer, J R Bickenbach, J A Rothnagel, et al.
American Journal of Obstetrics and Gynecology|January 1, 1995
Fetal Doppler and behavioral responses during hypoglycemia induced with the insulin clamp technique in pregnant diabetic womenE A Reece, Z Hagay, A B Roberts, et al.
Pageof 33

Showing results (271-280 of 325) with videos related to

Sort By:
Pageof 33
Proceedings of the National Academy of Sciences of the United States of America|September 15, 1993
Characterization of distinct functional domains of transforming growth factor betaJ K Burmester, S W Qian, A B Roberts, et al.
Surgery Annual|January 1, 1991
Operative ultrasound: ten years of experienceJ Machi, B Sigel, H A Zaren, et al.
The Journal of Biological Chemistry|January 15, 2000
The Smad4 activation domain (SAD) is a proline-rich, p300-dependent transcriptional activation domainM P de Caestecker, T Yahata, D Wang, et al.
The Journal of Clinical Investigation|November 1, 1996
Autoimmunity associated with TGF-beta1-deficiency in mice is dependent on MHC class II antigen expressionJ J Letterio, A G Geiser, A B Kulkarni, et al.
The Journal of Biological Chemistry|November 29, 1996
Binding affinity of transforming growth factor-beta for its type II receptor is determined by the C-terminal region of the moleculeS W Qian, J K Burmester, M L Tsang, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 15, 1986
Effects of transforming growth factor beta on the functions of natural killer cells: depressed cytolytic activity and blunting of interferon responsivenessA H Rook, J H Kehrl, L M Wakefield, et al.
Cancer Research|September 1, 1994
Prevention of breast cancer in the rat with 9-cis-retinoic acid as a single agent and in combination with tamoxifenM A Anzano, S W Byers, J M Smith, et al.
The Journal of Biological Chemistry|December 8, 1995
Characterization of the promoter region of the human transforming growth factor-beta type II receptor geneH W Bae, A G Geiser, D H Kim, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 1, 1993
Inhibition of skin development by overexpression of transforming growth factor beta 1 in the epidermis of transgenic miceK Sellheyer, J R Bickenbach, J A Rothnagel, et al.
American Journal of Obstetrics and Gynecology|January 1, 1995
Fetal Doppler and behavioral responses during hypoglycemia induced with the insulin clamp technique in pregnant diabetic womenE A Reece, Z Hagay, A B Roberts, et al.
Pageof 33